Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies
News | Structural Heart
CLASP IID One-year Data Confirm Safety and Efficacy of Edwards Pascal System for Degenerative Mitral Regurgitation

October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized ...

Home October 31, 2023
Home
The findings will impact the interventional treatment of High Bleeding Risk patients
News | Ventricular Assist Devices (VAD)
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

Home October 31, 2023
Home
Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis
News | Endovascular Aortic Repair
Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

Home October 30, 2023
Home
New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US
News | Structural Heart
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

Home October 26, 2023
Home
News | TCT
Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

Home October 26, 2023
Home
News | TCT
New Study Reveals Inequities in Access to Mechanical Circulatory Support in US Patients with Cardiogenic Shock

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

Home October 25, 2023
Home
News | TCT
Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

Home October 25, 2023
Home
Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices
News | Pulmonary Embolism
REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...

Home October 25, 2023
Home
Clinical research validates utility of IVL in complex nodular and eccentric calcium
News | Left Atrial Appendage (LAA) Occluders
ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023

October 25, 2023 — ConcertAI's TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for ...

Home October 25, 2023
Home
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
News | Left Atrial Appendage (LAA) Occluders
Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...

Home October 25, 2023
Home
News | TCT
TCT 2023 Shark Tank Innovation Competition Winner Recognized for Pioneering Approach to Pulmonary Arterial Hypertension and Congenital Heart Disease (PAH-CHD) Treatment

October 25, 2023 — For its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in ...

Home October 25, 2023
Home
Figure 1: A PROTECT III study analysis demonstrates that 82.5% of Impella-supported HRPCI patients have features in all three high-risk factor domains – comorbidities, complex coronary anatomy and adverse hemodynamics.
News | Heart Valve Technology
Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium

October 24, 2023 —  Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

Home October 24, 2023
Home
News | Cardiovascular Business
Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays

October 23, 2030 — Global medical devices and solutions provider Mindray has announced the introduction and global ...

Home October 23, 2023
Home
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
News | Hemodynamic Support Devices
Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23

October 23, 2023 — Supira Medical, Inc., a Shifamed portfolio company, announced that the company's percutaneous ...

Home October 23, 2023
Home
Published late-breaking clinical data presented at TCT 2023
News | Heart Failure
Gene Discoveries Could Help Prevent Deadly Coronary Artery Disease

October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium ...

Home October 20, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now